⏳ Fetching live dividend data...
Home › Calculator › RSLS Dividend Calculator 2026
ReShape Lifesciences Inc. · NASDAQ
Price: $3.92 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RSLS → $1951266529.34M in 10 years · $162,294,901,526,523.75/month
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open RSLS position with:
Real after-tax yield depends on where you live and how you hold RSLS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 51.02% | 48.22% | $5,102 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 43.37% | 40.57% | $4,337 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 40.82% | 38.02% | $4,082 / yr |
| 🇬🇧 UK ISA | 0% | 51.02% | 48.22% | $5,102 / yr |
| 🇬🇧 UK Taxable | 8.75% | 46.56% | 43.76% | $4,656 / yr |
| 🇨🇦 TFSA | 0% | 51.02% | 48.22% | $5,102 / yr |
| 🇨🇦 CA Taxable | 25% | 38.27% | 35.47% | $3,827 / yr |
| 🇦🇺 Super (pension) | 15% | 43.37% | 40.57% | $4,337 / yr |
| 🇦🇺 AU Taxable | 30% | 35.71% | 32.91% | $3,571 / yr |
| 🇩🇪 DE Taxable | 26.375% | 37.56% | 34.76% | $3,756 / yr |
| 🇫🇷 FR Taxable | 30% | 35.71% | 32.91% | $3,571 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
RSLS pays quarterly — 4 times per year. Next ex-div: TBD.
How RSLS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RSLS sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RSLS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →